Nonalcoholic fatty liver disease and type 2 diabetes: where do Diabetologists stand?

被引：77
|
作者：
Shaheen Tomah
Naim Alkhouri
Osama Hamdy
机构：
[1] Joslin Diabetes Center,Research Division
[2] Harvard Medical School,Department of Medicine
[3] University of Texas (UT) Health,Texas Liver Institute
来源：
Clinical Diabetes and Endocrinology | / 6卷 / 1期
关键词：
Type 2 diabetes; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Pathophysiology; Awareness; Screening; Treatment;
D O I：
10.1186/s40842-020-00097-1
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Type 2 diabetes, congestive heart failure and nonalcoholic fatty liver disease
    Maechler, M.
    Vonbank, A.
    Larcher, B.
    Mader, A.
    Sprenger, L.
    Leiherer, A.
    Zanolin-Purin, D.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S214 - S214
  • [32] The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Xueyang Zhang
    Ran Bai
    Yong Jia
    Junwei Zong
    Yongbo Wang
    Yanan Dong
    International Journal of Diabetes in Developing Countries, 2020, 40 : 491 - 499
  • [33] Nonalcoholic Fatty Liver Disease The New Complication of Type 2 Diabetes Mellitus
    Bril, Fernando
    Cusi, Kenneth
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2016, 45 (04) : 765 - +
  • [34] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes: Common Pathophysiologic Mechanisms
    Saponaro, Chiara
    Gaggini, Melania
    Gastaldelli, Amalia
    CURRENT DIABETES REPORTS, 2015, 15 (06) : 1 - 13
  • [35] Type 2 Diabetes, Congestive Heart Failure, and Nonalcoholic Fatty Liver Disease
    Maechler, Maximilian
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Sprenger, Lukas
    Leiherer, Andreas
    Purin, Daniela
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2020, 69
  • [36] Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease
    Newton, Kimberly P.
    Hou, Jiayi
    Crimmins, Nancy A.
    Lavine, Joel E.
    Barlow, Sarah E.
    Xanthakos, Stavra A.
    Africa, Jonathan
    Behling, Cynthia
    Donithan, Michele
    Clark, Jeanne M.
    Schwimmer, Jeffrey B.
    JAMA PEDIATRICS, 2016, 170 (10)
  • [37] The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus
    Zhang, Xueyang
    Bai, Ran
    Jia, Yong
    Zong, Junwei
    Wang, Yongbo
    Dong, Yanan
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2020, 40 (04) : 491 - 499
  • [38] Nonalcoholic fatty liver disease and the risk of type 2 diabetes in the United States
    Clark, JM
    Diehl, AM
    Brancati, FL
    DIABETES, 2001, 50 : A38 - A39
  • [39] Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic
    Ismail, Mona H.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (06): : 485 - 492
  • [40] Pharmacotherapy of type 2 diabetes in patients with chronic liver disease: focus on nonalcoholic fatty liver disease
    Raschi, Emanuel
    Mazzotti, Arianna
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    Marchesini, Giulio
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (17) : 1903 - 1914
12345